Streetbeat News

Price Targets

SPOT

Keybanc analyst Justin Patterson maintains an Overweight rating on Spotify Technology (NYSE:SPOT) and raises the price target from $180 to $205.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 8:09 am

BYD

Over the past 3 months, 14 analysts have published their opinion on Boyd Gaming (NYSE:BYD) stock. The company has an average price target of $77.86 with a high of $85.00 and a low of $63.00. The average price target has increased by 4.45% over the past month.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 8:01 pm

CZR

Over the past 3 months, 5 analysts have published their opinion on Caesars Entertainment (NASDAQ:CZR) stock. The company has an average price target of $64.8, an increase of 8.91% from the previous average price target of $59.50. The analysts' ratings range from bullish to indifferent.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 8:00 pm

BAH

Stifel analyst Bert Subin has reiterated a Buy rating on Booz Allen Hamilton Holding Corporation (BAH) and raised the price target from $110 to $125. The analyst predicts that AI-enabled contracts will be key to the company's medium-term success, estimating potential annual sales from these contracts to be $200 million - $800 million. The company is seen as the largest provider of AI services to the federal government, and the emergence of a burgeoning AI opportunity likely makes Booz's premium multiple deserved.

Portfolio Pulse from Shivani Kumaresan

July 13, 2023 | 6:53 pm

AZTA

CYRX

Cryoport Inc's shares are trading lower after the company released preliminary results for Q2 FY23 and updated its revenue expectations for FY23. The company expects Q2 sales of $56.5 million - $57.5 million, a decrease of 11% compared to Q2 2022 and below the consensus of $67.4 million. Cryoport also lowered its FY23 sales outlook to $233 million - $243 million, down from prior guidance of $270 million - $290 million. Despite this, analysts remain bullish on the company's long-term return.

Portfolio Pulse from Vandana Singh

July 13, 2023 | 6:52 pm

TMO

Credit Suisse has upgraded Thermo Fisher Scientific Inc (NYSE:TMO) to Outperform from Neutral, with a price target of $620. The analyst cites the company's strong position to navigate post-pandemic demand correction, diversified portfolio, and growth prospects in services businesses. Despite potential downward revision of guidance, the analyst believes Thermo Fisher's long-term growth opportunities remain intact.

Portfolio Pulse from Vandana Singh

July 13, 2023 | 6:33 pm

DFLI

Chardan Capital analyst Brian Dobson has reiterated a 'Buy' rating on Dragonfly Energy Hldgs (NASDAQ:DFLI) and maintained a $10 price target.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 6:03 pm

JNJ

Johnson & Johnson (NYSE:JNJ) has received various analyst ratings in the last quarter, with 2 bullish, 2 somewhat bullish, and 3 indifferent. The average 12-month price target for JNJ, according to 7 analysts, is $165.43, a 10.14% increase from the previous average of $150.20.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 6:01 pm

TGTX

B. Riley Securities analyst Mayank Mamtani has reiterated a 'Buy' rating on TG Therapeutics (NASDAQ:TGTX) and maintained a price target of $42.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 5:58 pm

SILV

Stifel analyst Stephen Soock has maintained a 'Buy' rating on SilverCrest Metals (AMEX:SILV) and raised the price target from C$12.5 to C$13.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 5:15 pm